Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Alana Horowitz
The Selective Angiotensin II Type 2 Receptor Agonist, Compound 21, Attenuates the Progression of Lung Fibrosis and Pulmonary Hypertension in an Experimental Model of Bleomycin-Induced Lung Injury
Frontiers in Physiology
Physiology
Related publications
Reduction of Bleomycin Induced Lung Fibrosis by Candesartan Cilexetil, an Angiotensin II Type 1 Receptor Antagonist
Thorax
Pulmonary
Respiratory Medicine
The Angiotensin II Type 2 Receptor Agonist Compound 21 Is Protective in Experimental Diabetes-Associated Atherosclerosis
Diabetologia
Internal Medicine
Endocrinology
Metabolism
Diabetes
Prostaglandin D2 Attenuates Bleomycin-Induced Lung Inflammation and Pulmonary Fibrosis
PLoS ONE
Multidisciplinary
2-Methoxyestradiol Attenuates Bleomycin-Induced Pulmonary Hypertension and Fibrosis in Estrogen-Deficient Rats
Vascular Pharmacology
Molecular Medicine
Physiology
Pharmacology
Bleomycin-Induced Lung Injury
Journal of Cancer Research
Thrombin-Activatable Fibrinolysis Inhibitor Deficiency Attenuates Bleomycin-Induced Lung Fibrosis
American Journal of Pathology
Forensic Medicine
Pathology
Aryl Hydrocarbon Receptor Signals Attenuate Lung Fibrosis in the Bleomycin-Induced Mouse Model for Pulmonary Fibrosis Through Increase of Regulatory T Cells
Arthritis Research & Therapy
IGF1R Deficiency Attenuates Acute Inflammatory Response in a Bleomycin-Induced Lung Injury Mouse Model
Scientific Reports
Multidisciplinary
Implantation of Fetal Rat Lung Fragments Into Bleomycin-Induced Pulmonary Fibrosis
Journal of Thoracic and Cardiovascular Surgery
Respiratory Medicine
Pulmonary
Cardiovascular Medicine
Surgery
Cardiology
